These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 31349865)
1. Nocebo effects of a simplified package leaflet compared to unstandardised oral information and a standard package leaflet: a pilot randomised controlled trial. Prediger B; Meyer E; Büchter R; Mathes T Trials; 2019 Jul; 20(1):458. PubMed ID: 31349865 [TBL] [Abstract][Full Text] [Related]
2. Nocebo effects and participant information leaflets: evaluating information provided on adverse effects in UK clinical trials. Kirby N; Shepherd V; Howick J; Betteridge S; Hood K Trials; 2020 Jul; 21(1):658. PubMed ID: 32680561 [TBL] [Abstract][Full Text] [Related]
3. Positively Framed Risk Information in Patient Information Leaflets Reduces Side Effect Reporting: A Double-Blind Randomized Controlled Trial. Webster RK; Weinman J; Rubin GJ Ann Behav Med; 2018 Oct; 52(11):920-929. PubMed ID: 30346496 [TBL] [Abstract][Full Text] [Related]
4. Patient information leaflets (PILs) for UK randomised controlled trials: a feasibility study exploring whether they contain information to support decision making about trial participation. Gillies K; Huang W; Skea Z; Brehaut J; Cotton S Trials; 2014 Feb; 15():62. PubMed ID: 24548781 [TBL] [Abstract][Full Text] [Related]
5. The OMACS-PIL study: a randomised controlled trial within the OMACS observational study. Culliford L; Brierley R; Clout M; Evans R; Maishman R; Phillips D; Tabusa H; Reeves B; Rogers CA Trials; 2019 Dec; 20(1):772. PubMed ID: 31881927 [TBL] [Abstract][Full Text] [Related]
6. Utility of patient information leaflet and perceived impact of its use on medication adherence. Al Jeraisy M; Alshammari H; Albassam M; Al Aamer K; Abolfotouh MA BMC Public Health; 2023 Mar; 23(1):488. PubMed ID: 36918823 [TBL] [Abstract][Full Text] [Related]
7. Preference of patient information leaflets over standard drug monographs by patients prescribed hydrochlorothiazide, nifedipine and enalapril. Gossell-Williams M; Bennett O; Dias Y; Foster K; Houston M; Wright K; Fairclough Z West Indian Med J; 2012 Jun; 61(3):271-9. PubMed ID: 23155986 [TBL] [Abstract][Full Text] [Related]
8. Risk perception of oral cancer in smokers attending primary care: a randomised controlled trial. Humphris GM; Freeman R; Clarke HM Oral Oncol; 2004 Oct; 40(9):916-24. PubMed ID: 15380170 [TBL] [Abstract][Full Text] [Related]
9. Using short information leaflets as recruitment tools did not improve recruitment: a randomized controlled trial. Brierley G; Richardson R; Torgerson DJ J Clin Epidemiol; 2012 Feb; 65(2):147-54. PubMed ID: 21889304 [TBL] [Abstract][Full Text] [Related]
10. The Effect of Positively Framing Side-Effect Risk in Two Different Formats on Side-Effect Expectations, Informed Consent and Credibility: A Randomised Trial of 16- to 75-Year-Olds in England. Webster RK; Rubin GJ Drug Saf; 2020 Oct; 43(10):1011-1022. PubMed ID: 32557180 [TBL] [Abstract][Full Text] [Related]
11. Knowledge of oral cancer, distress and screening intentions: longer term effects of a patient information leaflet. Boundouki G; Humphris G; Field A Patient Educ Couns; 2004 Apr; 53(1):71-7. PubMed ID: 15062907 [TBL] [Abstract][Full Text] [Related]
12. Immediate knowledge increase from an oral cancer information leaflet in patients attending a primary health care facility: a randomised controlled trial. Humphris GM; Ireland RS; Field EA Oral Oncol; 2001 Jan; 37(1):99-102. PubMed ID: 11120490 [TBL] [Abstract][Full Text] [Related]
13. Development of written information for antiretroviral therapy: comprehension in a Tanzanian population. Mwingira B; Dowse R Pharm World Sci; 2007 Jun; 29(3):173-82. PubMed ID: 17120132 [TBL] [Abstract][Full Text] [Related]
14. Relative importance of informational items in participant information leaflets for trials: a Q-methodology approach. Innes K; Cotton S; Campbell MK; Elliott J; Gillies K BMJ Open; 2018 Sep; 8(9):e023303. PubMed ID: 30185580 [TBL] [Abstract][Full Text] [Related]
15. Retention strategies are routinely communicated to potential trial participants but often differ from what was planned in the trial protocol: an analysis of adult participant information leaflets and their corresponding protocols. Murphy E; Gillies K; Shiely F Trials; 2024 Jun; 25(1):372. PubMed ID: 38858790 [TBL] [Abstract][Full Text] [Related]
16. Written medicines information for South African HIV/AIDS patients: does it enhance understanding of co-trimoxazole therapy? Mansoor L; Dowse R Health Educ Res; 2007 Feb; 22(1):37-48. PubMed ID: 16763073 [TBL] [Abstract][Full Text] [Related]
17. Simple, illustrated medicines information improves ARV knowledge and patient self-efficacy in limited literacy South African HIV patients. Dowse R; Barford K; Browne SH AIDS Care; 2014; 26(11):1400-6. PubMed ID: 24975116 [TBL] [Abstract][Full Text] [Related]
18. A randomised controlled trial of patient information leaflets as a medication counselling aid. McNeill R; Chin P; Coberger E; Doogue M Intern Med J; 2019 Mar; 49(3):328-332. PubMed ID: 30022574 [TBL] [Abstract][Full Text] [Related]
19. Randomised trial of the psychological effect of information about oral cancer in primary care settings. Humphris GM; Ireland RS; Field EA Oral Oncol; 2001 Oct; 37(7):548-52. PubMed ID: 11564574 [TBL] [Abstract][Full Text] [Related]
20. Patient information leaflets for placebo-controlled surgical trials: a review of current practice and recommendations for developers. Cousins S; Huttman M; Blencowe N; Tsang C; Elliott D; Blazeby J; Beard DJ; Campbell MK; Gillies K Trials; 2024 May; 25(1):339. PubMed ID: 38778336 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]